Central Nervous System: Drowsiness, headache, lightheadedness, tinnitus, and vertigo may occur. Rare instances of confusion, insomnia, and nightmares.
Dermatological: Reports of skin rash, pruritus, urticaria, and photosensitivity reactions. Very rarely, erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis, or other bullous reactions.
Gastrointestinal system: Abdominal pain, constipation, diarrhoea, dyspepsia, flatulence, nausea, oesophagitis, stomatitis, and vomiting may occur. Rare instances of peptic ulceration, perforation, or gastrointestinal bleeding, sometimes severe, particularly in the elderly (see also Precautions). Reports of rare cases of gastritis.
Genitourinary system: Laboratory tests of renal function may be disturbed, such as elevated creatinine or urea.
Haematological system: Reports of blood count disturbances in patients taking meloxicam, some of which have been attributed to therapy; anaemia, leucocytopenia, and thrombocytopenia.
There are isolated reports of agranulocytosis in patients taking meloxicam and other drugs with myelotoxic potential.
Hepatic system: Liver function tests may show transitory disturbance, such as elevation of bilirubin or transaminase levels.
Immunological: Rare reports of angioedema, and anaphylactic or anaphylactoid reactions.
Pulmonary system: patients allergic to aspirin or other NSAIDS have experienced asthma attacks.
Sensory systems: Rare reports of visual disturbances, including blurred vision.
View ADR Monitoring Form